.Attribute Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint calls for addition of patients with MASLD and also measurement of liver end results in cardio-- renal-- metabolic tests, when information suggest mechanistically probable advantages and medical safety-- and also describes factors to consider for test design as well as regulatory commendation.